NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financi... (nch of Qutenza; the tolerability profile...)

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results

Date:7/31/2009

nch of Qutenza; the tolerability profile and/or benefits of NeurogesX' product candidates and potential development partners for NeurogesX' early-stage products. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to the FDA may request additional clinical trials or other information prior to granting approval for Qutenza; any regulatory approvals which are received may be limited to certain indications; NeurogesX' product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy or tolerability; and other difficulties or delays in, clinical development of, and obtaining regulatory approval for NeurogesX' product candidates. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

    NeurogesX, Inc.                     The Ruth Group
    Stephen Ghiglieri                   Sara Pellegrino (investors)
    Chief Financial Officer             (646) 536-7002
    (650) 358-3310                      spellegrino@theruthgroup.com

                                        Jason Rando (media)
                                        (646) 536-7025
                                        jrando@theruthgroup.com

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. NeurogesX Added to Russell 3000 Index
2. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
3. NeurogesX to Present at Needham Life Sciences Conference
4. NeurogesX Receives European Commission Approval for Qutenza(TM)
5. NeurogesX Reports First Quarter 2009 Results
6. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
7. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
8. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
9. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
10. NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
11. NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference

Post Your Comments:

(Date:11/19/2009)...Gene Synthesis Companies Form International Gene S...tices in Risk Reduction ,Five Member Companies R...pacity , (PRWEB) November...e synthesis companies today announced agreement th...promote biosecurity in the gene synthesis industry...

(Date:11/18/2009)...le to find explosive materials and persons who hav... the National Institute of Standards and Technolog...land Security, has developed a new certified refer...905, Trace Particulate Explosives. Compatible with...be helpful in calibrating, testing and developing ...

(Date:11/18/2009)...Newswire-FirstCall/ -- Masimo (Nasdaq: MASI ), ...Through Motion and Low-Perfusion pulse oximetry, a...ne of the largest healthcare Group Purchasing Orga... purchasing agreement for "gold standard" Masimo S...preferred contract pricing to Uni.H.A.,s 53 member...

(Date:11/18/2009).... 18 Algenol Biofuels LLC, develop...he technology group The Linde Group have agreed to...er to identify the optimum management of carbon di...lgae and photobioreactor technology. This cooperat...cost-efficient technologies that capture, store, t...

Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2 World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3 World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4 New NIST trace explosives standard slated for homeland security duty 2 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3 Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4 Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2 Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3

[0] World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol [0] New NIST trace explosives standard slated for homeland security duty [0] Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products [0] Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae

... Quarter 2007: Total Net Revenue of $627 Million; ... EPS $0.35, Fiscal Year 2007: Total Net Revenue R... $1.27; 2007 Adjusted EPS $1.37, CORONA, Cal... WPI ), a leading specialty pharmaceutical,company... financial results,for its fiscal year ended Decem...

...IA, Md., Feb. 20 Cylex, Inc., today announced the...nical research study in,which the level of cellula...antation using the Company,s proprietary ImmuKnow(... patients that may be at risk for early,acute tran...he first three,months following transplantation., ...

..., Feb. 20 HealthAware, a leading supplier of,inno... today the launch of,VascularAware, the newest dis...rAware is designed to help people who may be at ri...cts nearly 10 million adult Americans,according to...the VascularAware disease module extends the Compa...

Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection HealthAware Introduces Its VascularAware Cardiovascular Disease Module

(Date:11/20/2009)...ngle bacterial gene into yeast, researchers from D...chieved three improvements in bioethanol productio... less acetate and elimination of the major by-prod...d in the scientific journal Applied and Environme...is made by the yeast Saccharomyces cerevisiae from...

(Date:11/20/2009)...search Center (ERC) has been awarded a grant from ...hods of recovering and reusing the heat that would...ssion process in a carbon capture system. The goal...apture and sequestration, or storage (CCS), and th...itted into the atmosphere by coal-fired power plan...

(Date:11/19/2009)...s are revealing the genetic instructions inside co...ize, has one of the most complex sequences of DNA ...n genomicist David Schwartz, who was one of more t...ence . , "The maize genome is a true maze full ...led would-be sequencers for years," says Schwartz....

Breaking Biology News(10 mins):Delft breakthrough in bioethanol production from agricultural waste 2 Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2 Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3 Sweet corn story begins in UW-Madison lab 2 Sweet corn story begins in UW-Madison lab 3 Aflac Again Honored as One of the 100 Best Places to Work in IT 49224 1 Aflac Again Honored as One of the 100 Best Places to Work in IT 49224 2 Aflac Again Honored as One of the 100 Best Places to Work in IT 49224 3 Study finds reproductive health effects from low doses of bisphenol A 49222 1 Study finds reproductive health effects from low doses of bisphenol A 49222 2 Targeting children effective use of limited supplies of flu vaccine and could help control flu spread 8881 1 Targeting children effective use of limited supplies of flu vaccine and could help control flu spread 8881 2

[0] Delft breakthrough in bioethanol production from agricultural waste [0] Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants [0] Sweet corn story begins in UW-Madison lab

...nternational, Inc.,(OTC Bulletin Board: BKYI), a l... wireless public safety, announced today that the ...issuance of a patent for the company,s "Match Temp..." method. , The benefits of the technology p...provide another layer of defense against hackers a...

...e today, it,s easy to forget that a dam and pond s...adison,s Franbrook Farm Research Station in southw...gone, and acres of plants, both native and weedy, ...theless, memories of the dam remain, and by diggin...ers are now unearthing them. Writing in a special ...

..., 2008. The first 5-year forest inventory report f...ailable to the public: California,s Forest Resourc...ysis Report., Here are some key findings from the ...te,s 100 million acres;19 million acres is publicl...terface account for most of the housing growth in ...

Other Biology News:BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2 Researchers examine role of soil patterns in dam restoration 2 Researchers examine role of soil patterns in dam restoration 3 Forest inventories in California include more than trees 2 Forest inventories in California include more than trees 3

BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use Researchers examine role of soil patterns in dam restoration Forest inventories in California include more than trees

Taq DNA Polymerase from QIAGEN

Handy 100V Power Supply from Major Science

...ce Smart Minis 150V power supply (Cat. No. Minis 1...plies designed to meet most electrophoresis needs ... 150V power supply is capable of running DNA/RNA e... for individuals to have his/her own power supply ...

BD BioCoat Collagen IV 35 mm Culture Dishes from BD Biosciences - Discovery Labware

Biology Products:

Taq DNA Polymerase from QIAGEN Handy 100V Power Supply from Major Science Pink Minis 150V Power Supply from Major Science BD BioCoat Collagen IV 35 mm Culture Dishes from BD Biosciences - Discovery Labware

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financi...(nch of Qutenza; the tolerability profile...)